Elevation of serum KL-6 levels during treatment with tumor necrosis factor-α inhibitor in patients with psoriasis

被引：9
|
作者：
Mabuchi, Tomotaka [1 ]
Yamaoka, Hanako [1 ]
Kawai, Mayu [1 ]
Ota, Tami [1 ]
Ozawa, Akira [1 ]
机构：
[1] Tokai Univ, Dept Dermatol, Sch Med, Isehara, Kanagawa 2591193, Japan
来源：
JOURNAL OF DERMATOLOGY | 2014年 / 41卷 / 12期
关键词：
AD HOC COMMITTEE; RHEUMATOID-ARTHRITIS; BIOLOGICAL DMARDS; JAPAN COLLEGE; SAFETY;
D O I：
10.1111/1346-8138.12681
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1136 / 1137
页数：2
相关论文
共 50 条
  • [1] Elevation of serum KL-6 in patients with psoriasis treated with anti-tumour necrosis factor- therapy
    Higashi, Y.
    Tada, K.
    Shimokawa, M.
    Kawai, K.
    Kanekura, T.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2016, 41 (01) : 88 - 90
  • [2] Change in Serum KL-6 Level during Biologic Treatment for Psoriasis
    Hoashi, Toshihiko
    Miyazaki, Shun
    Ozaki, Saeko
    Ichiyama, Susumu
    Ito, Michiko
    Kanda, Naoko
    Saeki, Hidehisa
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2023, 90 (02) : 194 - 201
  • [3] Infliximab and adalimumab, unlike ustekinumab, increase serum KL-6 levels in Japanese patients with psoriasis
    Yanaba, Koichi
    Umezawa, Yoshinori
    Sakakihara, Reiko
    Chiba, Miki
    Ito, Toshihiro
    Kikuchi, Sota
    Fukuchi, Osamu
    Asahina, Akihiko
    Saeki, Hidehisa
    Nakagawa, Hidemi
    JOURNAL OF DERMATOLOGY, 2015, 42 (08) : 828 - 829
  • [4] Serum KL-6 Elevation and Possible Pulmonary Involvement in Patients with Rheumatoid Arthritis Treated with Biological Agents
    Takahashi, Kenji
    Nakamura, Hiroshi
    Takenouchi, Kenji
    Iizawa, Norishige
    Koiwa, Masahito
    Sato, Akiko
    Mochizuki, Yusuke
    Watanabe, Hiroshi
    Takai, Shinro
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2014, 81 (06) : 364 - 371
  • [5] Elevation of serum KL-6 levels in 3 patients with rheumatoid arthritis treated with adalimumab
    Koiwa, Masahito
    Goto, Susumu
    Takenouchi, Kenji
    Takahasi, Kenji
    Kamada, Toshikazu
    Nakamura, Hiroshi
    MODERN RHEUMATOLOGY, 2012, 22 (01) : 147 - 151
  • [6] Psoriasis patients generate increased serum levels of autoantibodies to tumor necrosis factor-α and interferon-α
    Bergman, R.
    Ramon, M.
    Wildbaum, G.
    Avitan-Hersh, E.
    Mayer, E.
    Shemer, A.
    Karin, N.
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2009, 56 (03) : 163 - 167
  • [7] Elevation of KL-6 serum levels in clinical trials of tumor necrosis factor inhibitors in patients with rheumatoid arthritis: a report from the Japan College of Rheumatology Ad Hoc Committee for Safety of Biological DMARDs
    Harigai, Masayoshi
    Takamura, Akito
    Atsumi, Tatsuya
    Dohi, Makoto
    Hirata, Shintaro
    Kameda, Hideto
    Nagasawa, Hayato
    Seto, Yohei
    Koike, Takao
    Miyasaka, Nobuyuki
    MODERN RHEUMATOLOGY, 2013, 23 (02) : 284 - 296
  • [8] Subacute thyroiditis in a patient with psoriasis treated with a tumor necrosis factor-α inhibitor
    Wei, Yu-An
    Chuang, Wan-Chi
    Hong, Chien-Hui
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2018, 57 (07) : 869 - 871
  • [9] Serum anti-Mullerian hormone levels in women with rheumatoid arthritis during tumor necrosis factor-α inhibitor treatment: Exploratory research
    Isojima, Sakiko
    Miura, Yoko
    Saito, Mayu
    Yajima, Nobuyuki
    Miwa, Yusuke
    Kasama, Tsuyoshi
    OBSTETRIC MEDICINE, 2019, 12 (04) : 186 - 189
  • [10] Hepatitis-B reactivation during treatment with tumor necrosis factor-α blocker adalimumab in a patient with psoriasis arthritis
    Kouba, M.
    Rudolph, S. E.
    Hrdlicka, P.
    Zuber, M. A.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (1-2) : 23 - 26
12345